China SXT Pharmaceuticals, Inc. Announces Pricing of a $15 Million PIPE Financing

TAIZHOU, China, April 17, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company......

China SXT Pharmaceuticals, Inc. Receives National High-tech Enterprise Qualification

TAIZHOU, China, Apr. 2, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc.  (the "Company") (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the rese......

China SXT Pharmaceuticals, Inc. Announces Financial Results for the Six Months Ended September 30, 2018

TAIZHOU, China, March 28, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc.  (the "Company") (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the re......

China SXT Pharmaceuticals, Inc. Announces Final Closing of Initial Public Offering

TAIZHOU, China and NEW YORK, Jan. 4, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (the "Company") (NASDAQ: SXTC), a specialty pharmaceutical company foc......

China SXT Pharmaceuticals, Inc. Announces First Closing of Initial Public Offering

TAIZHOU, China and New York, Jan. 2, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc.  (the "Company") (NASDAQ:SXTC), a specialty pharmaceutical company foc......

China SXT Pharmaceuticals, Inc. Announces Effectiveness of Registration Statement on Form F-1 and Pricing the Initial Public Offering of its Ordinary Shares at $4.00 per Share

......

Dr. Jingzhen Deng Invited on the Special Speech “Currently, the Research and Development Trend Discussion on Traditional Chinese Medicine”

News from China SXT: Dr. Jingzhen Deng, the Chief Scientific Officer of our company, was invited for giving a special talk about“Currently, the Research and Development Trend Discussion......

Nasdaq’s Head of Healthcare Listings Shares 2018 Predictions for Biotech IPOs

Nasdaq: What is the current market environment for biotech initial public offerings and biotech listings overall?Saxe: I expect that 2018 will demonstrate positive momentum for biotech listings o......

Dr. Jingzhen Deng Invited to Speak at the Upcoming “4th World Congress and Exhibition on Antibiotics and Antibiotics Resistance

Dear Dr. Jing-Zhen Deng,Greeting from Antibiotics 2018!!It is my sincere pleasure to invite you to speak at the upcoming "4th World Congress and Exhibition on Antibiotics and Antib......